HomeAREVF • OTCMKTS
add
AREV Life Sciences Global Corp
Previous close
$0.010
Year range
$0.00020 - $0.11
Market cap
2.76M CAD
Avg Volume
133.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 11.98K | -94.96% |
Net income | -28.92K | 87.98% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | 1.86K | 101.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.82K | -88.02% |
Total assets | 213.30K | -40.88% |
Total liabilities | 1.38M | 14.22% |
Total equity | -1.16M | — |
Shares outstanding | 31.76M | — |
Price to book | -0.25 | — |
Return on assets | -13.45% | — |
Return on capital | 2.98% | — |
Cash Flow
Net change in cash
| (CAD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -28.92K | 87.98% |
Cash from operations | -5.58K | -165.01% |
Cash from investing | — | — |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -5.58K | -241.62% |
Free cash flow | 15.26K | -24.83% |
About
Headquarters
Website
